MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
108 hedge funds and large institutions have $1.56B invested in Mirati Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 29 increasing their positions, 17 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
71% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 17
33% more funds holding
Funds holding: 81 → 108 (+27)
Holders
108
Holding in Top 10
9
Calls
$16.7M
Puts
$7.45M
Top Buyers
| 1 | +$54.4M | |
| 2 | +$40.3M | |
| 3 | +$39.5M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$36.7M |
| 5 |
PA
Perceptive Advisors
New York
|
+$33.7M |
Top Sellers
| 1 | -$33M | |
| 2 | -$20.9M | |
| 3 | -$12.5M | |
| 4 |
Millennium Management
New York
|
-$11.7M |
| 5 |
PC
PointState Capital
New York
|
-$9.16M |